Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in Drug Delivery dealmaking



2.1. Introduction

2.2. Drug Delivery partnering over the years

2.3. Most active Drug Delivery dealmakers

2.4. Drug Delivery partnering by deal type

2.5. Drug Delivery partnering by therapy area

2.6. Deal terms for Drug Delivery partnering

2.6.1 Drug Delivery partnering headline values

2.6.2 Drug Delivery deal upfront payments

2.6.3 Drug Delivery deal milestone payments

2.6.4 Drug Delivery royalty rates



Chapter 3 – Leading Drug Delivery deals



3.1. Introduction

3.2. Top Drug Delivery deals by value



Chapter 4 – Most active Drug Delivery dealmakers



4.1. Introduction

4.2. Most active Drug Delivery dealmakers

4.3. Most active Drug Delivery partnering company profiles



Chapter 5 – Drug Delivery contracts dealmaking directory



5.1. Introduction

5.2. Drug Delivery contracts dealmaking directory



Chapter 6 – Drug Delivery dealmaking by technology type



Chapter 7 – Partnering resource center



7.1. Online partnering

7.2. Partnering events

7.3. Further reading on dealmaking



Appendices



Appendix 1 – Drug Delivery deals by company A-Z



Appendix 2 – Drug Delivery deals by stage of development



Discovery

Preclinical

Phase I

Phase II

Phase III

Regulatory

Marketed

Formulation



Appendix 3 – Drug Delivery deals by deal type



Asset purchase

Assignment

Bigpharma outlicensing

Co-development

Collaborative R&D

Co-market

Co-promotion

CRADA

Cross-licensing

Development

Distribution

Equity purchase

Evaluation

Grant

Joint venture

Licensing

Litigation

Manufacturing

Marketing

Material transfer

Option

Promotion

Research

Settlement

Spin out

Sub-license

Supply

Technology transfer

Termination

Warranty



Appendix 4 – Drug Delivery deals by therapy area



Appendix 5 –Deal type definitions



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from Current Partnering



Table of figures


Figure 1: Drug Delivery partnering since 2014

Figure 2: Active Drug Delivery dealmaking activity since 2014

Figure 3: Drug Delivery partnering by deal type since 2014

Figure 4: Drug Delivery partnering by disease type since 2014

Figure 5: Drug Delivery deals with a headline value

Figure 6: Drug Delivery deals with an upfront value

Figure 7: Drug Delivery deals with a milestone value

Figure 8: Drug Delivery deals with a royalty rate value

Figure 9: Top Drug Delivery deals by value since 2014

Figure 10: Most active Drug Delivery dealmakers since 2014

Figure 11: Online partnering resources

Figure 12: Forthcoming partnering events